Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,261 across all filing types
Latest filing 2024-06-07 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization and securities listing requirements for the period 01.05.2024 to 31.05.2024. It is addressed to stock exchanges and signed by the company secretary. The document is short (3297 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance filing related to securities and share dematerialization. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-06-07 English
We are enclosing herewith the certificate dated June 3, 2024 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization and securities listing requirements for the period 01.05.2024 to 31.05.2024. It is addressed to stock exchanges and signed by the company secretary. The document is short (3297 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents that do not fit other specific categories.
2024-06-07 English
Updates
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the appointment of a senior management personnel, Ms. Shikha Mirchandani Chatrath, as Director - Commercial Excellence, BD & Strategy. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in senior management. The content includes details about the appointment date, term, and a brief profile of the appointee. There are no financial statements, earnings data, or other report contents. The document is clearly an announcement of a management change rather than a full report or presentation. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 3061 characters, which is consistent with a brief announcement rather than a full report.
2024-06-01 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of ....
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the appointment of a senior management personnel, Ms. Shikha Mirchandani Chatrath, as Director - Commercial Excellence, BD & Strategy. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in senior management. The content includes details about the appointment, effective date, and a brief profile of the appointee. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a management change rather than a full report or other filing type. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 3061 characters, which is consistent with a typical management change announcement.
2024-06-01 English
Copy of Newspaper Publication
Regulatory Filings
2024-05-31 English
Please find the enclosed newspaper publication for the Postal Ballot Notice dated May 27, 2024.
Regulatory Filings
2024-05-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.